
System Status Messages
Time | Market | Status |
---|---|---|
21:27:38 ET | NASDAQ BX Post - Trade PSX NASDAQ Options BX Options PHLX NASDAQ Futures ISE GEMX MRX | Systems are operating normally |
Regulatory Messages
Time | Market | Status |
---|---|---|
16:09:33 ET | NASDAQ BX PSX | Trading in Porch Group Inc. - Warrant (PRCHW) was halted today at 16:05:05 ET due to additional information requested from the company related to the redemption of the warrants today. It is anticipated (PRCHW) will be suspended on Nasdaq effective 4/19/21. Please call +1-800-537-3929 or +1-301-978-8500 if you have any questions. |
IPO Messages
Time | Market | Status |
---|---|---|
16:24:56 ET | PHLX | Nasdaq PHLX has approved the transfer of GFN from Wolverine Trading to Belvedere Trading effective before the opening of business on Monday, April 19, 2021. Please contact Nasdaq Option Listings at 215-496-1266 with any questions. |
12:44:14 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) has officially opened for trading. Time: 12:41:15 For additional information please contact Nasdaq Trading Services at (212) 231-5180. |
12:39:34 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
12:30:08 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
12:19:08 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
12:10:59 ET | NASDAQ | IPO Notice Update: The initial public offering of AKOYA BIOSCIENCES, INC (AKYA) has officially opened for trading. Time: 12:09:34 For additional information please contact Nasdaq Trading Services at (212) 231-5180. |
12:09:07 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
12:06:29 ET | NASDAQ | IPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
12:00:07 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:55:23 ET | NASDAQ | IPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:52:58 ET | NASDAQ | IPO Notice Update: The initial public offering of company BIOMEA FUSION, INC (BMEA) has officially opened for trading. Time:11:51:12 For additional information please contact Nasdaq Trading Services at (212) 231-5180. |
11:50:32 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:45:01 ET | NASDAQ | IPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:41:29 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:40:02 ET | NASDAQ | IPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:36:51 ET | NASDAQ | IPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:31:13 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:30:18 ET | NASDAQ | IPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:25:10 ET | NASDAQ | IPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:21:28 ET | NASDAQ | IPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:20:37 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:15:23 ET | NASDAQ | IPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:12:13 ET | NASDAQ | IPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:10:08 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:05:29 ET | NASDAQ | IPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
11:01:25 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
10:56:21 ET | NASDAQ | IPO Notice Update: The initial public offering of security, AKYA - AKOYA BIOSCIENCES, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
10:50:18 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
10:50:04 ET | NASDAQ | IPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
10:42:03 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
10:41:43 ET | NASDAQ | IPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
10:30:25 ET | NASDAQ | IPO Notice Update: The initial public offering of security, BMEA - BIOMEA FUSION, INC, remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
10:30:20 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
10:20:08 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
10:10:19 ET | NASDAQ | IPO Notice Update: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs. |
07:53:01 ET | NASDAQ | IPO Notice: The initial public offering of Akoya BioSciences, Inc. (AKYA) will be released on Nasdaq today for quotation at 10:35 a.m. ET and will be eligible for trading at approximately 10:45 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs. |
07:44:43 ET | NASDAQ | IPO Notice: The initial public offering of Biomea Fusion, Inc. (BMEA) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs. |
07:33:38 ET | NASDAQ | IPO Notice: The initial public offering of Recursion Pharmaceuticals, Inc. (RXRX) will be released on Nasdaq today for quotation at 9:50 a.m. ET and will be eligible for trading at approximately 10:00 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs. |
Self-Help Messages
Time | Market | Status |
---|---|---|
21:28:03 ET | NASDAQ BX PSX NASDAQ Options NASDAQ Futures BX Options PHLX ISE GEMX MRX | There are no messages available |